Skip to main content
. 2019 Apr 15;14(4):e0215322. doi: 10.1371/journal.pone.0215322

Table 3. Factors associated with non-completion of latent tuberculosis infection treatment.

590 contacts (close and frequent contacts) to whom treatment had been prescribed; contacts were detected through contact tracing of sputum smear-positive pulmonary tuberculosis cases. Barcelona 2008–2016.

LTBI treatment
  Non-completion Completion p-value** OR aOR
    n = 72, n (%*) n = 518, n (%*)
Age <40 years 52 (13.3) 338 (86.7) 0.25 1
≥40 years 20 (10.1) 179 (89.9) 0.7 (0.4–1.3)
Sex Man 40 (12.1) 291 (87.9) 0.92 1
Woman 32 (12.4) 227 (87.6) 1.0 (0.6–1.7)
Country of origin Spain 20 (8.3) 222 (91.7) 0.02 1 1
Foreign-born 50 (14.7) 290 (85.3) 1.9 (1.1–3.3) 2.0 (1.0–3.7)
Type of contact Close 58 (11.4) 452 (88.6) 0.12 1
Frequent 14 (17.5) 66 (82.5) 1.6 (0.9–3.1)
Setting Home 55 (10.9) 449 (89.1) 0.02 1 1
Community 17 (19.8) 69 (80.2) 2.0 (1.1–3.7) 1.8 (0.8–3.9)
TST/IGRA Conversion Yes 4 (5.9) 64 (94.1) 0.09 1
No 68 (13.0) 454 (87.0) 2.4 (0.8–6.8)
Smoking habit No 34 (10.1) 303 (89.9) 0.59 1
Yes 16 (11.8) 120 (88.2) 1.2 (0.6–2.2)
DM No 48 (10.1) 428 (89.9) 0.25 1
Yes 5 (16.7) 25 (83.3) 1.8 (0.6–4.9)
HIV infection No 53 (10.4) 456 (89.6) 0.07 1
Yes 1 (50.0) 1 (50.0) 8.6 (0.5–139.6)
Alcohol abuse No 48 (11.0) 389 (89.0) 0.53 1
Yes 2 (7.1) 26 (92.9) 0.6 (0.1–2.7)

LTBI: latent tuberculosis infection; OR: odds ratio; aOR: odds ratio adjusted by country of origin and setting of contact; TST/IGRA conversion: conversion in tuberculin screen test or IGRA seroconversion; DM: diabetes mellitus.

*Percentage over the total without missing values;

**p-value for the univariate analyses;.